Clinical Trial Update: Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Placebo [Phase 3]

View source ↗

Summary

Phase 3 trial for SHP640 vs placebo in treating adenoviral conjunctivitis was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenoviral Conjunctivitis

Drugs mentioned

• SHP640 (SHP640)

Snippet

Sponsor: Shire | Conditions: Adenoviral Conjunctivitis | Phase 3 | Status: TERMINATED | Results posted: 2020-05-29